ADA

Published by Daniel at June 1, 2023

Ada is a fast Artificial intelligence-powered symptom checker available 24 hours a day, seven days a week, no matter where the patient is. This medical AI platform was developed by physicians and scientists and is supported by a ten-million-strong consumer base. It aims to simplify healthcare experiences and allow people to care for themselves by supporting better health outcomes and clinical excellence with intelligent technology.

Ada AI Aspects

Ada assists patients in understanding, managing, and receiving treatment for their symptoms in minutes, using trusted medical skills. Their enterprise technologies help customers produce outstanding results by incorporating medical experience with clinical excellence.

Ada aims to assess and connect customers with a healthcare service in an accurate and timely manner.

Provide their customers with an accurate wellness report and a smooth digital interface
Create detailed symptom coverage to help ensure therapeutic consistency
Provides reliable health information within minutes

Allows to treat diseases constructively

Secures patient privacy and confidentiality

Classifies care urgency into eight advice levels
Offers a customizable treatment routing that helps their customers find the best clinical or interactive care providers
Provides wellness tips and appointment-making 24/7

Increases telehealth and virtual treatment participation

Improves the systems’ and network’s loyalty
Steered customers away from unnecessary medical treatment when appropriate.(1)

How Ada's AI Works

Clinical precision and medical oversight from human doctors have been the bases since the beginning. In addition, Ada’s reports suggest that it is 35% more accurate, on average, than other symptom assessment apps.
The software will initially start an assessment and run probabilistic reasoning with the collected data. This information will be aggregated into feedback which a medical expert reviews. This process optimizes the knowledge base. It then transforms the users’ assessment securely reports into medical professionals’ IT system using the platform’s adaptive interface. This process gives medical professionals more informed time with patients and reduces administrative burden. The platform also integrates with other systems, simplifying the care journey and helping patients tell their story only once.

During the Covid-19 pandemic, Ada’s app managed care demand and supplied users with free customizable integration. Ada’s reach extended to support companies’ pandemic response in 8 countries. It identified risk factors that impacted symptom severity, indicating the likelihood of COVID-19 infection. It also relieved the collapsed health services by suggesting safe and sensible next steps. It is available to guide users in English, German, Arabic, Spanish, Italian, Portuguese, and Indonesian.

The Ada software is continuously optimized based on 20 million health assessments. It complies with relevant medical device safety, effectiveness requirements, and data security standards, such as HIPAA, MDD, GDPR, ISO 27001, and BiM Badge.

Regarding user experience, 97% of patients found Ada easy to use and 90% of interactions showed patients felt improved rapport with healthcare professionals.

Ada has 99% coverage of common, rare, high-risk obstetric, pediatric, and mental health conditions. Additionally, 33.3% more patients could have had their rare disease identified in their first documented clinical consultation.(2)

Ada Health’s financial aspects

Ada Health announced a raising of $47 million in the latest funding round. Ada Health is soon to expand into new markets. Currently based in Europe, with locations in Berlin, Munich, and London, the company is set to hire more staff and open a new office in the US.

Since its launch, Ada’s app has become one of the most popular and renowned healthcare tools on the app market and was downloaded over a million times six months after becoming established. The easy-to-use platform has become an essential tool worldwide, especially in countries with limited access to medical care. The investment will enable Ada Health to further its growth, enter new markets, expand its skilled workforce, and develop its service offering.(3)

The Validity of Digital Symptom Assessment Apps for Suggesting Conditions and Urgency Treatment

A study was conducted to evaluate the effectiveness of eight symptom-assessment apps, compared with each other with seven tested general practitioners (GPs) based on their coverage and the accuracy of the diagnosed condition and level of urgency.

By comparing the symptom assessment apps and GPs, apps were found to differ in terms of coverage, urgency advice, and accuracy of suggested conditions. A remarkable difference was noted regarding the condition accuracy between the top-performing app (Ada) and other apps.

Urgency advice performance differed between the GPs and between apps with a range of tested-GP safe advice of 6.0% and a SD of 2.5%. According to the apps, the range of safe advice was 17.8% and the SD 7.4%. The results of this study are relevant for home users of symptom assessment apps and healthcare providers offering advice to their patients on which symptom assessment apps to choose.

This study’s findings suggest the future potential of AI-based symptom assessment technology in diagnostic decision support and further treatment.(4)

Artificial Intelligence Algorithms That Support Specific Diagnoses Are Increasing Exponentially

A transparent system regarding decision-making is required to guarantee accountability in the event of incorrect diagnosis or treatment complications. This platform provides transparency to help patients and physicians act autonomously.

Machine learning algorithms can examine the data and expose it to experts who will provide feedback based on their knowledge. The ultimate goal is that machines and humans will work and think together.(5)

Patients’ Utilization and Perception of an AI-Based Symptom Assessment and Advice Technology in a British Primary Care Center

During the process of deciding when to seek medical attention, multiple factors play a role. They include trust, convenience, and cost. Using symptom assessment technologies with AI assistance may help individuals make more accurate decisions. This study evaluated symptom assessment technology’s usability, acceptability, and utility in a primary care setting. Patients were invited to use the ADA symptom assessment mobile app. Over a 3-month period, 523 participants completed the self-assessment about the presenting complaint using a smartphone. Results showed that the digital system checker was highly rated in usability and acceptability in a primary care setting.(6)

Can a Decision Support System Accelerate Rare Disease Diagnosis?

The lack of knowledge and awareness regarding rare diseases often delays their diagnosis by months or even years. The application of diagnostic support systems could improve the diagnosis of rare diseases by suggesting differential diagnoses depending on the case input. The study evaluated a diagnostic support system (Ada DX) potential to provide accurate rare disease suggestions early during rare disease cases. Results showed that Ada DX suggested the correct pathology earlier than the clinical diagnosis between the top five disease suggestions in 53.8% of the cases and as the top disease suggestion 37.6% of the time. The median advantage for correct disease suggestion compared to the clinical diagnosis was three months (50%) for the top five and one months (21%) for the top fit. The correct diagnosis was suggested at the first documented patient visit in 33.3% (top 5 fits) and 16.1% of cases (top fit), respectively.(7)

References